Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications.

Pasinetti GM.

Planta Med. 2012 Oct;78(15):1614-9. doi: 10.1055/s-0032-1315377. Epub 2012 Sep 21. Review. Erratum in: Planta Med. 2013 Jan;79(1):92.

2.

Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration.

Ho L, Chen LH, Wang J, Zhao W, Talcott ST, Ono K, Teplow D, Humala N, Cheng A, Percival SS, Ferruzzi M, Janle E, Dickstein DL, Pasinetti GM.

J Alzheimers Dis. 2009;16(1):59-72. doi: 10.3233/JAD-2009-0916.

3.

Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease.

Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein DL, Thiyagarajan M, Percival SS, Talcott ST, Pasinetti GM.

FASEB J. 2006 Nov;20(13):2313-20.

PMID:
17077308
4.

Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease.

Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM.

J Neurosci. 2008 Jun 18;28(25):6388-92. doi: 10.1523/JNEUROSCI.0364-08.2008.

5.

Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical.

Smid SD, Maag JL, Musgrave IF.

Food Funct. 2012 Dec;3(12):1242-50. doi: 10.1039/c2fo30075c. Review.

PMID:
22929970
6.

Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Ho L, Ferruzzi MG, Janle EM, Wang J, Gong B, Chen TY, Lobo J, Cooper B, Wu QL, Talcott ST, Percival SS, Simon JE, Pasinetti GM.

FASEB J. 2013 Feb;27(2):769-81. doi: 10.1096/fj.12-212118. Epub 2012 Oct 24.

7.

Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.

Rolyan H, Scheffold A, Heinrich A, Begus-Nahrmann Y, Langkopf BH, Hölter SM, Vogt-Weisenhorn DM, Liss B, Wurst W, Lie DC, Thal DR, Biber K, Rudolph KL.

Brain. 2011 Jul;134(Pt 7):2044-56. doi: 10.1093/brain/awr133. Epub 2011 Jun 14.

PMID:
21672962
8.

Diet and Alzheimer's disease risk factors or prevention: the current evidence.

Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A.

Expert Rev Neurother. 2011 May;11(5):677-708. doi: 10.1586/ern.11.56. Review.

PMID:
21539488
9.

Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment.

Wang J, Ferruzzi MG, Ho L, Blount J, Janle EM, Gong B, Pan Y, Gowda GA, Raftery D, Arrieta-Cruz I, Sharma V, Cooper B, Lobo J, Simon JE, Zhang C, Cheng A, Qian X, Ono K, Teplow DB, Pavlides C, Dixon RA, Pasinetti GM.

J Neurosci. 2012 Apr 11;32(15):5144-50. doi: 10.1523/JNEUROSCI.6437-11.2012.

10.

Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.

Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L.

Biochim Biophys Acta. 2015 Jun;1852(6):1202-8. doi: 10.1016/j.bbadis.2014.10.006. Epub 2014 Oct 12. Review.

12.

Inhibiting amyloid β-protein assembly: Size-activity relationships among grape seed-derived polyphenols.

Hayden EY, Yamin G, Beroukhim S, Chen B, Kibalchenko M, Jiang L, Ho L, Wang J, Pasinetti GM, Teplow DB.

J Neurochem. 2015 Oct;135(2):416-30. doi: 10.1111/jnc.13270. Epub 2015 Sep 2.

13.

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.

Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, Kruse CG, Verhaagen J, Swaab DF.

Brain. 2010 Dec;133(Pt 12):3699-723. doi: 10.1093/brain/awq258. Epub 2010 Oct 1.

PMID:
20889584
14.

S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.

Zhang W, Zhang W, Li Z, Hao J, Zhang Z, Liu L, Mao N, Miao J, Zhang L.

Pharmacol Biochem Behav. 2012 Jan;100(3):361-9. doi: 10.1016/j.pbb.2011.09.012. Epub 2011 Oct 2.

PMID:
21993310
15.

α7 nicotinic acetylcholine receptors in Alzheimer's disease: neuroprotective, neurotrophic or both?

Hernandez CM, Dineley KT.

Curr Drug Targets. 2012 May;13(5):613-22. Review.

PMID:
22300028
16.

Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?

Cederholm T, Palmblad J.

Curr Opin Clin Nutr Metab Care. 2010 Mar;13(2):150-5. doi: 10.1097/MCO.0b013e328335c40b. Review.

PMID:
20019606
17.

Possible involvement of programmed cell death pathways in the neuroprotective action of polyphenols.

Bastianetto S, Krantic S, Chabot JG, Quirion R.

Curr Alzheimer Res. 2011 Aug;8(5):445-51. Review.

PMID:
21605053
18.

Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.

Götz J, Schild A, Hoerndli F, Pennanen L.

Int J Dev Neurosci. 2004 Nov;22(7):453-65. Review.

PMID:
15465275
19.

Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice.

Fernandez-Vizarra P, Lopez-Franco O, Mallavia B, Higuera-Matas A, Lopez-Parra V, Ortiz-Muñoz G, Ambrosio E, Egido J, Almeida OF, Gomez-Guerrero C.

Brain. 2012 Sep;135(Pt 9):2826-37. doi: 10.1093/brain/aws195.

PMID:
22961553
20.

Preventing cognitive decline in preclinical Alzheimer's disease.

Riedel WJ.

Curr Opin Pharmacol. 2014 Feb;14:18-22. doi: 10.1016/j.coph.2013.10.002. Epub 2013 Nov 13. Review.

PMID:
24565007

Supplemental Content

Support Center